Cotton, M. F., Madhi, S. A., Luabeya, A. K., Tameris, M., Hesseling, A. C., Shenje, J., Schoeman, E., Hatherill, M., Desai,
S., Kapse, D., Brückner, S., Koen, A., Jose, L., Moultrie, A., Bhikha, S., Walzl, G., Gutschmidt, A., Kotze, L. A., Allies,
D. L., Loxton, A. G., Shaligram, U., Abraham, M., Johnstone, H., Grode, L., Kaufmann, S. H. E., & Kulkarni, P. S. (2022). Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies:
a randomised, phase 2 non-inferiority double-blind controlled trial. Lancet Infectious Diseases.
doi:10.1016/S1473-3099(22)00222-5.
